| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2883169 | The Annals of Thoracic Surgery | 2007 | 7 Pages |
Abstract
This randomized, double-blind study indicates that statin therapy before cardiopulmonary bypass is associated with reduction of circulating markers of inflammation and increased neutrophil apoptosis. These data support a routine inclusion of statins as an adjuvant pharmacologic therapy before cardiopulmonary bypass surgery.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Massimo MD, Amedeo MD, Cristiano MD, Giuseppe MD, Costanza MD, Germano MD, Elvio MD,